Drug Type Mesenchymal stem cell therapy |
Synonyms bone marrow-derived mesenchymal stromal cells(The University of Queensland), Bone-marrow derived MSCs(The University of Queensland) |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung transplant rejection | Phase 2 | AU | 31 Mar 2020 | |
Allograft Rejection | Phase 2 | AU | 21 Apr 2017 | |
Cardiomyopathy, Dilated | Phase 2 | ES | 31 Mar 2013 | |
Coronary Artery Disease | Phase 2 | ES | 31 Mar 2013 | |
Idiopathic cardiomyopathy | Phase 2 | ES | 31 Mar 2013 | |
Liver Cirrhosis, Alcoholic | Phase 1 | US | 20 Jun 2019 |
Phase 3 | 475 | (Bone Marrow Derived MSCs) | kqhbmkrsya(dspamsrxbj) = iyrvlntjki ifupwkqymb (oamorlnevy, sdaetyqzgz - rbwrfdymsj) View more | - | 27 Jul 2023 | ||
Adipose-derived MSCs (Adipose-derived MSCs) | kqhbmkrsya(dspamsrxbj) = rjwqasbdsh ifupwkqymb (oamorlnevy, hzzdssnmmo - btloazchsw) View more | ||||||
HOVON-113 (EHA2022) Manual | Phase 3 | 41 | Mesenchymal stromal cell | yxjowmzlfi(wepkvmucnt) = corxgfnfmk vczjeinmvm (ipcdoedujg ) View more | Negative | 12 May 2022 | |
placebo | yxjowmzlfi(wepkvmucnt) = pqskxdqxjl vczjeinmvm (ipcdoedujg ) View more |